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   bjective: The aim of the present study was to determine the in vitro maximum inhibitory dilution (MID) of two chlorhexidine-
based oral mouthwashes (CHX): Noplak®, Periogard®, and one polyhexamethylene biguanide-based mouthwash (PHMB):
Sanifill Premium® against 28 field Staphylococcus aureus strains using the agar dilution method. Materials and Methods: For
each product, decimal dilutions ranging from 1/10 to 1/655,360 were prepared in distilled water and added to Mueller Hinton
Agar culture medium. After homogenization, the culture medium was poured onto Petri dishes. Strains were inoculated using
a Steers multipoint inoculator and dishes were incubated at 37ºC for 24hours. For reading, MID was considered as the maximum
dilution of the mouthwash still capable of inhibiting microbial growth. Results: Sanifill Premium® inhibited the growth of all
strains at 1/40 dilution and of 1 strain at 1/80 dilution. Noplak® inhibited the growth of 23 strains at 1/640 dilution and of all 28
strains at 1/320 dilution. Periogard® showed inhibited growth of 7 strains at 1/640 dilution and of all 28 strains at 1/320 dilution.
Data were submitted to Kruskal-Wallis statistical test, showing significant differences between the mouthwashes evaluated
(p<0.05). No significant difference was found between Noplak® and Periogard® (p>0.05). Sanifill Premium® was the least
effective (p<0.05). Conclusion: It was concluded that CHX-based mouthwashes present better antimicrobial activity against S.
Aureus than the PHMB-based mouthwash.
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INTRODUCTION
Mouthwashes have been used for centuries19 with the
objective of reducing the amount of microorganisms in the
oral cavity14. These chemical agents have been widely
employed in the fields of Preventive Dentistry and
Periodontics2,10,13. Among the microorganisms present in the
oral cavity, the reduction in the number of Staphylococcus
aureus prior to surgical procedures has been associated
with a lower incidence of infective endocarditis and
postoperative infections4.
Chlorhexidine gluconate (CHX) is a cationic biguanide
with broad-spectrum antimicrobial action, whose
effectiveness in decreasing the formation of dental biofilm
(plaque) and gingivitis has been demonstrated in clinical
studies1,5,6,13. An important characteristic of chlorhexidine is
its substantivity or persistence of action, which consists of
the ability of this product to bind to oral tissues and remain
active for long periods after application1.
The antimicrobial properties of mouthwashes containing
CHX and other antimicrobial agents have been assessed in
vivo and in vitro, with excellent results for CHX-based
solutions3,4,7,11,15,16,20.
Polyhexamethylene biguanide hydrochloride (PHMB) is
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a polymeric biguanide with broad antimicrobial spectrum
against both Gram-positive and Gram-negative bacteria8,9.
PHMB has been used for several years as an antiseptic
agent in Medicine12. Welk, et al.23 demonstrated in clinical
studies that PHMB-based mouthwashes inhibited biofilm
formation and reduced contamination in the oral cavity,
suggesting that these solutions may be an alternative for
prevention of dental biofilm.
The purpose of this study was to determine in vitro the
maximum inhibitory dilution (MID) of two mouthwashes
containing 0.12% chlorhexidine gluconate and one
mouthwash containing 0.35% PHMB and to compare their
action against 28 Staphylococcus aureus field strains using
the agar dilution method.
MATERIAL AND METHODS
The following mouthrinses were evaluated: Periogard®
(Colgate-Palmolive, Ind. Brasileira, Osasco, SP, Brazil), Noplak®
(Laboratório Daudt Oliveira Ltda., Rio de Janeiro, RJ, Brazil)
and Sanifill Premium® (Facilit Odontológica e Perfumaria,
Brazil) (Table 1).
Determination of the maximum inhibitory dilution (MID)
was performed in duplicate by double serial dilution (from 1/
10 through 1/655.360) in test tubes (20x200mm) with 2.0 mL of
sterile distilled water. After dilutions were made, 18.0 mL of
Mueller Hinton Agar culture medium (Difco®) were added to
each tube, and the resulting solutions were poured onto Petri
dishes (20x100mm).
The microbial inoculum (~108UFC/mL) with turbidity
equivalent to a 0.5 McFarland standard was prepared in test
tubes (15x125 mm) with saline, using 28 young S. aureus field
strains previously incubated at 35°C for 24 h. S. aureus strains
were collected from the oral and nasal cavities of volunteer
undergraduate students.
Microorganisms were seeded using a Steers multipoint
inoculator21. The Steers inoculator consists of two metallic
plates: one of these plates has 25 wells into which 200 µL of
each standardized microbial inoculum were transferred. The
other plate has 25 metallic needles that fit into the wells. Using
these needles, the inoculi were seeded onto the surface of
the culture medium in Petri dishes containing different
dilutions of the mouthwashes. Since the Steers inoculator
has 25 wells and 28 strains were evaluated, three inoculi (5.0
µL) were seeded equidistantly from each other, approximately
one centimeter from the periphery of each Petri dish, using an
automatic pipette.
The dishes were then incubated at 37°C for 24 hours, and
readings were performed considering the MID as the greatest
dilution of mouthwash capable of inhibiting growth of all
evaluated strains, following the methodology by Wade and
Product
Periogard®
Noplak®
Sanifill Premium®
Composition
0.12% chlorhexidine gluconate, water, glycerin, ethanol, polysorbate 20, flavoring agents, -
sodium saccharin, FD&C Blue n°1
0.12% chlorhexidine gluconate, water, 3.5% ethyl alcohol, hydroxyethylcellulose, sodium
cyclamate, glycerin, menthol, hydrogenated castor oil, sodium saccharin, sorbitol, CI-19.140
and 42.090, flavoring agents, demineralized water
0.05% sodium fluoride (226ppm), sorbitol 70%, sodium benzoate, 0.35%
polyhexamethylene biguanide chlorhydrate, methylsilanol, sodium cocoanphoacetate,
disodium monophosphate, disodium phosphate, sodium saccharin, CI-19.140 and 42.090,
deionized water
TABLE 1- Formulation of the antiseptic solutions evaluated
Sanifill Premium Noplak Periogard
Inhibited Cumulative Inhibited Cumulative Inhibited Cumulative
strains data strains data strains data
Dilution No. % No. % No. % No. % No. % No %
1/640 0 0.0 0 0.0 23 82.1 23 82.1 7 25.0 7 25.0
1/320 0 0.0 0 0.0 5 17.9 28 100.0 21 75.0 28 100.0
1/160 0 0.0 0 0.0
1/80 2 7.1 2 7.1
1/40 26 92.9 28 100.0
TABLE 2- Percentage of S aureus strains inhibited (from a total of 28 strains) by each dilution of the mouthwashes tested
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Statistical analysis
Results were expressed as scores determined from
minimum to maximum dilution and comparison between all
groups was performed using Kruskal-Wallis nonparametric
test. When this test showed significant difference between
the groups, Dunn’s multiple comparison test, which allows
two-by-two comparison between groups, was applied.
Significance level was set at 5% (p<0.05).
RESULTS
The mouthwashes evaluated in this study presented
different MIDs (Table 2). No significant difference was found
between Noplak® and Periogard® (p>0.05). Sanifill Premium®
was the least effective agent (p<0.05).
DISCUSSION
Chlorhexidine gluconate mouthwashes are available in the
market at concentrations ranging from 0.12% and 0.2%. Smith,
et al.20, using the plaque formation index, compared in vivo
the dental biofilm-inhibiting properties of mouthwashes
containing 0.12% and 0.2% chlorhexidine gluconate. Both
formulations presented better results than other mouthwashes
without CHX. The CHX-based mouthwashes evaluated in
this study contain 0.12% CHX.
Albuquerque Jr, et al.4 assessed the MID of a mouthwash
containing 0.12% chlorhexidine gluconate against 25 S. aureus
strains, and found that all of them were inhibited up to a 1/80
dilution of the mouthwash. In the present study, the S. aureus
strains were inhibited by Periogard® and by Noplak® up to a
1/320 dilution. This difference in the results of both studies
may be related to the different sources of the microorganisms.
Albuquerque Jr, et al.4 used S. aureus strains collected from
the oral cavity, while in the present study the microorganisms
were retrieved from the oral and nasal cavities of the patients.
A study by Herrera, et al.11 demonstrated that four
mouthwashes containing the same active ingredient (0.12%
chlorhexidine) but different formulations demonstrated
statistically significant differences in their antimicrobial
activity, both in vitro and in vivo. For the in vitro antimicrobial
activity test, 20 selected bacterial species were evaluated.
The in vivo test consisted of salivary bacterial count. The
samples were cultured both aerobically and anaerobically.
The formulation with alcohol was more active than those
without alcohol, except for the formulation with chlorhexidine
and cetylpyridinium chloride, which presented better
antimicrobial activity. The addition of other active
components should be further evaluated because
chlorhexidine is highly cationic and may be inactivated by
anionic substances11.
Our results demonstrated that the CHX-based
mouthwashes (Noplak® and Periogard®) were more effective
in inhibiting bacterial growth in comparison to the PHMB-
based product (Sanifill Premium®).
The antimicrobial activity of mouthwashes containing
PHMB has been evaluated in several in vivo studies17,18,23. In
one of these works, Rosin, et al.17, using a method that
measured bacterial counts on the tooth surface and oral
mucosa, demonstrated that a mouthwash with 0.04% PHMB
was more capable of inhibiting biofilm/dental plaque
formation, compared to a negative control (placebo); however,
the PHMB-based product was not as efficient as a mouthwash
containing 0.12% chlorhexidine. This result is in agreement
with our study, in which the PHMB-based mouthwash was
not as effective as the CHX-based mouthwashes.
In another in vivo study in which a method to measure
bacterial counts on tooth surface and mucosa was used,
Rosin, et al.18, observed that a mouthwash containing 0.12%
PHMB was more capable of inhibiting biofilm/dental plaque,
in comparison to a negative control (placebo), but no
statistically significant difference was observed between the
FIGURE 1- Graph depicting MID values obtained for each solution evaluated
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PHMB-based mouthwash and a product with 0.12%
chlorhexidine. Regarding the ability to reduce the number of
intraoral bacteria, the chlorhexidine-based product performed
better than the PHMB-based mouthwash. In our study, the
evaluated mouthwash contains 0.35% PHMB, and presented
lower MID values than CHX-based mouthwashes containing
0.12% CHX.
An in vivo study23 using a method to determine bacterial
counts on tooth surface and mucosa demonstrated that a
solution containing 0.12% chlorhexidine was more capable of
inhibiting and reducing biofilm/dental plaque than a
mouthwash containing 0.2% PHMB. However, the PHMB-
based mouthwash presented similar results to the
chlorhexidine solution in reducing the number of bacteria
present on the oral mucosa.
The mouthwashes evaluated by Rosin, et al.17,18 and Welk,
et al.23 had a lower concentration of PHMB than the product
tested in the present study (Sanifill Premium®). Despite its
higher concentration of PHMB, Sanifill Premium® showed
lower MID than the chlorhexidine-based mouthwashes.
CONCLUSIONS
The mouthwashes containing 0.12% chlorhexidine
(Noplak® and Periogard®) presented higher MID values than
that containing 0.35% PHMB (Sanifill Premium®) against
salivary S. aureus. It was concluded that CHX-based
mouthwashes have better antimicrobial activity than the
PHMB-based mouthwash.
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